ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Abituzumab Biosimilar - Anti-Integrin alpha V Antibody (Biotin) (A332089)

Recombinant humanized monoclonal antibody to Integrin alpha V (Biotin) for Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Abituzumab Biosimilar - Anti-Integrin alpha V Antibody (Biotin)
Description
Recombinant humanized monoclonal antibody to Integrin alpha V (Biotin).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG2
Conjugate

Biotin

Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
Synonyms
CD51, Integrin alpha-V, ITGAV, MSK8, Vitronectin receptor, Vitronectin receptor subunit alpha, VNRA, VTNR
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Abituzumab Biosimilar - Anti-Integrin alpha V Antibody (Biotin) (A332089)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with Integrin alpha V

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.4% Relevancy Score
99% Relevancy Score